[{"data": {"name": "Bruk av TNF-\u03b1-antistoff ved inflammatorisk tarmsykdom", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "Tom Martinsen", "@type": "Person"}, {"name": "Ralph Herter", "@type": "Person"}, {"name": "Jan Dybdahl", "@type": "Person"}, {"name": "Helge Waldum", "@type": "Person"}], "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "https://tidsskriftet.no/sites/default/files/pdf2010--273-7.pdf", "encodingFormat": "application/pdf"}], "publisher": {"name": "Norwegian Medical Association", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.4045/tidsskr.09.0642", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCfTFoLscDRiW-CTBUTieQujbr3-CDvVPGShe2ktB-CR1uhBwYyFhPJ", "propertyID": "ISCC"}], "datePublished": "2010-01-01"}, "schema": "schema.org", "mediatype": "application/ld+json"}]